End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
116.6 BDT | -2.59% | -2.18% | -20.25% |
08:00am | Beximco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 | CI |
03-04 | Beximco names Iqbal Ahmed as managing director | AN |
Evolution of the average Target Price on Beximco Pharmaceuticals Limited
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- BXPHARMA Stock
- Consensus Beximco Pharmaceuticals Limited